StockNews.AI
VRPX
Benzinga
186 days

Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate

1. Virpax Pharmaceuticals completed the Probudur study with positive results. 2. The study showed Probudur reduces pain in a rat model. 3. Probudur aims to improve pain control and reduce opioid use. 4. Preclinical studies indicate significant long-duration analgesia effects.

3m saved
Insight
Article

FAQ

Why Bullish?

Positive study results suggest growth potential for VRPX, similar to past successful drug approvals.

How important is it?

The Probudur study is central to VRPX's future, influencing long-term profitability.

Why Long Term?

The ongoing development of Probudur suggests sustained interest and value increase over time.

Related Companies

Related News